Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in LEXICON PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC previously held 0 shares of LXRX (LEXICON PHARMACEUTICALS INC), worth $0 as of 2025-Q1.
Final Value
$0
Final Shares
0
Total Value Change
-$189,008
Total Shares Change
-120,387
Other major holders of LXRX: FMR LLC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $0.57 |
0 |
| 2024-Q4 | Increased | 353,508 | +193.6% | $261,242 | 0.0% | $0.72 | 37 |
| 2024-Q3 | New | 120,387 | - | $189,008 | 0.0% | $1.60 | 35 |